The Role of Neuropsychiatric Symptoms in the Diagnosis of Early Parkinson’s Disease: a Systematic Review
Objective: This study aims to evaluate the role of neuropsychiatric symptoms in the diagnosis of Early Parkinson's Disease. Background: Neuropsychiatric symptoms (NPS) are important and…Duration of Illness and Response to Pimavanserin in Parkinson’s Disease Psychosis: Post-Hoc Analysis of Clinical Trial Data
Objective: To examine individual responses to pimavanserin in patients with Parkinson’s disease psychosis (PDP) initiating treatment <6 vs ≥6 months and <12 vs ≥12 months…Characteristics of Visual Hallucinations in Lewy Body Dementia
Objective: To investigate the risk and the content of visual hallucination (VH) among patients with Lewy body dementia (LBD) within the cultural background of Taiwan.…The Impact of Depression on Information Storage, Consolidation and Evocation Processes in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease without Dementia by Deep Brain Stimulation. Descriptive study of the ESDEPARK Scale.
Objective: To identify the clinical correlation between neurocognitive functioning in memory and depressive symptomatology in patients with IPDWD, assessed by a new scale (ESDEPARK) that…Life Course Sleep Duration Trajectories and Risk and Age at Onset of Parkinson’s Disease
Objective: To characterize life course sleep duration trajectories and examine their associations with PD risk and age at onset (AAO). Background: Sleep disturbances could be…Lung Function and the Risk of Parkinson’s Disease: A Population-based Cohort Study
Objective: The study aims to explore the association between lung function and the risk to develop PD. Background: Some researchers have noted a faster decline…Prevalence, demographic characteristics of Parkinson disease and associated comorbidities: An analysis of the Colombian Ministry of Health official registry
Objective: Conduct a descriptive analysis of the Colombian Parkinson’s disease population and its comorbidities using data from the Colombian Ministry of Health.Estimate the prevalence and…Levodopa response in pathology-confirmed Parkinson’s Disease, Multiple System Atrophy and Progressive Supranuclear Palsy
Objective: to describe the rate of levodopa response, phenotypical characteristics, prognostic implications and pathological features in a large cohort of patients with pathology-confirmed Parkinson’s disease…The Impact of Freezing of Gait on Falls over time in Parkinson’s disease
Objective: To quantify falls related to Freezing of Gait (FoG) versus unrelated to FoG as Parkinson’s disease progresses. Background: FoG is a debilitating symptom of…Evaluation of Effects of Levodopa and Subthalamic Nucleus Stimulation (STN-DBS) on Gait using Quantified Timed Up and Go Test in People with Parkinson’s Disease (PD)
Objective: This study evaluates effect of medication and stimulation on transfers and gait in people with PD post STN-DBS using an automated, quantitative assessment involving…
- « Previous Page
- 1
- …
- 57
- 58
- 59
- 60
- 61
- …
- 436
- Next Page »